PRAX Q4 2022 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$28M

Operating Income

-$41M

Net Income

-$41M

EPS (Diluted)

$-12.89

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$115M

Total Liabilities

$39M

Stockholders' Equity

$76M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$28M	$0	—
Operating Income	-$41M	-$59M	+29.3%
Net Income	-$41M	-$59M	+29.7%